JP6509833B2 - 免疫応答性を増強するための哺乳動物乳オステオポンチン - Google Patents

免疫応答性を増強するための哺乳動物乳オステオポンチン Download PDF

Info

Publication number
JP6509833B2
JP6509833B2 JP2016522645A JP2016522645A JP6509833B2 JP 6509833 B2 JP6509833 B2 JP 6509833B2 JP 2016522645 A JP2016522645 A JP 2016522645A JP 2016522645 A JP2016522645 A JP 2016522645A JP 6509833 B2 JP6509833 B2 JP 6509833B2
Authority
JP
Japan
Prior art keywords
opn
infection
mammal
osteopontin
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016522645A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016529217A (ja
JP2016529217A5 (OSRAM
Inventor
シュタウト クヴィストガード，アンネ
シュタウト クヴィストガード，アンネ
ラングボリ ヴェイセ，ペータル
ラングボリ ヴェイセ，ペータル
ドノヴァン，シャロン
エイチ．モナコ シーゲル，マルシア
エイチ．モナコ シーゲル，マルシア
エス． コムストック，サラ
エス． コムストック，サラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arla Foods AMBA
Original Assignee
Arla Foods AMBA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arla Foods AMBA filed Critical Arla Foods AMBA
Publication of JP2016529217A publication Critical patent/JP2016529217A/ja
Publication of JP2016529217A5 publication Critical patent/JP2016529217A5/ja
Application granted granted Critical
Publication of JP6509833B2 publication Critical patent/JP6509833B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dispersion Chemistry (AREA)
JP2016522645A 2013-07-05 2014-07-04 免疫応答性を増強するための哺乳動物乳オステオポンチン Active JP6509833B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361843185P 2013-07-05 2013-07-05
US61/843,185 2013-07-05
EP13175267 2013-07-05
EP13175267.7 2013-07-05
PCT/EP2014/064339 WO2015001092A1 (en) 2013-07-05 2014-07-04 Mammalian milk osteopontin for enhancing immune responsiveness

Publications (3)

Publication Number Publication Date
JP2016529217A JP2016529217A (ja) 2016-09-23
JP2016529217A5 JP2016529217A5 (OSRAM) 2017-08-03
JP6509833B2 true JP6509833B2 (ja) 2019-05-08

Family

ID=48740972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016522645A Active JP6509833B2 (ja) 2013-07-05 2014-07-04 免疫応答性を増強するための哺乳動物乳オステオポンチン

Country Status (18)

Country Link
US (3) US9956283B2 (OSRAM)
EP (1) EP3016673B1 (OSRAM)
JP (1) JP6509833B2 (OSRAM)
KR (1) KR102307002B1 (OSRAM)
CN (1) CN105407910B (OSRAM)
AU (1) AU2014286123B2 (OSRAM)
BR (1) BR112016000067B1 (OSRAM)
CA (1) CA2916821C (OSRAM)
CL (1) CL2015003803A1 (OSRAM)
DK (1) DK3016673T3 (OSRAM)
EA (1) EA034654B1 (OSRAM)
ES (1) ES2656474T3 (OSRAM)
MX (1) MX369925B (OSRAM)
NZ (1) NZ715430A (OSRAM)
PH (1) PH12015502844B1 (OSRAM)
PL (1) PL3016673T3 (OSRAM)
PT (1) PT3016673T (OSRAM)
WO (1) WO2015001092A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3095082A1 (en) * 2018-04-25 2019-10-31 Health And Happiness (H&H) Hong Kong Limited Combinations of osteopontin and 2'-fucosyllactose for use as medicaments
US10933097B1 (en) 2020-03-05 2021-03-02 King Saud University Method of treating a bacterial infection using colostrum
CN113424962A (zh) * 2020-09-21 2021-09-24 黑龙江飞鹤乳业有限公司 提高免疫力的营养组分、含有其的食品或保健品及其用途
EP4326758A4 (en) * 2021-04-20 2025-03-19 University of Cincinnati A vaccine adjuvant for infectious diseases
CN113475720B (zh) * 2021-06-15 2023-07-25 合生元（广州）健康产品有限公司 骨桥蛋白在增加肠道菌群多样性和增加肠道短链脂肪酸含量中的应用
CN118632706A (zh) 2022-01-31 2024-09-10 雀巢产品有限公司 包含骨桥蛋白（opn）的组合物
CN117337994A (zh) * 2023-10-11 2024-01-05 黑龙江飞鹤乳业有限公司 功能性组合物及该组合物的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056405A1 (en) * 1997-06-10 1998-12-17 Whitehead Institute For Biomedical Research A method of modulating immune response with osteopontin
CA2293492A1 (en) * 1997-06-11 1998-12-17 Martin Berry Cns neuroregenerative compositions and methods of use
MXPA01010332A (es) * 1999-04-15 2002-09-18 Childrens Medical Center Metodos y composiciones para modular una respuesta inmunitaria.
PT1244702E (pt) 2000-01-07 2006-08-31 Arla Foods Amba Processo para o isolamento da osteopontina do leite
WO2003008537A2 (en) * 2001-04-06 2003-01-30 Mannkind Corporation Epitope sequences
WO2003100007A2 (en) * 2002-05-24 2003-12-04 Schering-Plough Ltd. Eta-1 gene and methods for use
KR20130009866A (ko) * 2003-09-18 2013-01-23 아를라 푸즈 에이엠비에이 유아용 조제유
NZ546398A (en) * 2003-09-18 2009-03-31 Arla Foods Amba Infant formula
KR20090123115A (ko) * 2008-05-27 2009-12-02 한국생명공학연구원 오스테오폰틴을 유효성분으로 함유하는 자연살해세포분화용 조성물 및 이를 이용한 분화 방법
WO2012117119A1 (en) * 2011-03-03 2012-09-07 Arla Foods Amba Method for isolating osteopontin using feeds containing cmp or casein species
EA201491010A1 (ru) * 2011-12-07 2015-01-30 Арла Фудз Амба Варианты остеопонтина для применения в подавлении или предупреждении опухолевого роста и композиции, содержащие такие варианты остеопонтина

Also Published As

Publication number Publication date
WO2015001092A1 (en) 2015-01-08
MX369925B (es) 2019-11-25
EA201690057A1 (ru) 2016-07-29
EP3016673B1 (en) 2017-10-25
US9956283B2 (en) 2018-05-01
CL2015003803A1 (es) 2016-08-05
EP3016673A1 (en) 2016-05-11
USRE50281E1 (en) 2025-01-28
US20180289798A1 (en) 2018-10-11
MX2016000107A (es) 2016-06-07
CN105407910B (zh) 2019-12-03
DK3016673T3 (da) 2018-01-29
AU2014286123B2 (en) 2019-02-28
PH12015502844A1 (en) 2016-03-28
CA2916821C (en) 2023-10-03
KR102307002B1 (ko) 2021-10-05
PT3016673T (pt) 2018-01-30
BR112016000067B1 (pt) 2022-08-30
US20160136268A1 (en) 2016-05-19
PH12015502844B1 (en) 2016-03-28
CA2916821A1 (en) 2015-01-08
NZ715430A (en) 2022-01-28
KR20160030960A (ko) 2016-03-21
EA034654B1 (ru) 2020-03-03
PL3016673T3 (pl) 2018-04-30
ES2656474T3 (es) 2018-02-27
CN105407910A (zh) 2016-03-16
BR112016000067A2 (OSRAM) 2017-09-05
JP2016529217A (ja) 2016-09-23
US10772955B2 (en) 2020-09-15
AU2014286123A1 (en) 2016-01-21

Similar Documents

Publication Publication Date Title
USRE50281E1 (en) Mammalian milk osteopontin for enhancing immune responsiveness
Renz et al. The immunological basis of the hygiene hypothesis
Kusumo et al. Lactobacillus plantarum IS-10506 supplementation increases faecal sIgA and immune response in children younger than two years
Saliganti et al. Feeding probiotic Lactobacillus rhamnosus (MTCC 5897) fermented milk to suckling mothers alleviates ovalbumin-induced allergic sensitisation in mice offspring
Saliganti et al. Consumption of probiotic Lactobacillus rhamnosus (MTCC: 5897) containing fermented milk plays a key role in development of the immune system in newborn mice during the suckling–weaning transition
WO2000044402A1 (en) Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
US11883446B2 (en) Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses
US20220257752A1 (en) New use of cyclic dinucleotides
JP6219728B2 (ja) Ｆｏｘｐ３陽性制御性Ｔ細胞とＩＦＮ−γ産生ＩＬ−１０産生Ｔ細胞誘導を指標とした、経口免疫寛容物質スクリーニング方法及び経口免疫寛容増強組成物
Michael et al. Escherichia coli Nissle 1917 enhances efficacy of oral attenuated human rotavirus vaccine in a gnotobiotic piglet model. Vaccines (Basel). 2022; 10 (1): 83
Paul et al. An Overview of the Effects of Probiotics on Vaccine-Mediated Immune Response in Humans
EP4397318A1 (en) Immunostimulatory formulation, and cosmetic, food, feed additive, and quasi-drug containing said immunostimulatory formulation
Lu Effects of supplemental osteopontin on intestinal development and serum antibody responses to rotavirus vaccination in piglets
TW202517283A (zh) 包含源自蜂房哈夫尼菌的脂多糖及卡波姆的免疫增強用組合物
KR20240006134A (ko) 마이코박테리움 파라고르도네를 포함하는 면역 증강용 조성물
Siregar et al. The Difference Secretory Immunoglobulin A between Faeces Sample of Full Breastfeeding and Mixed Feeding Infant
Shunk Effect of bovine lactoferrin on T lymphocyte cell phenotype and function and the response to vaccination in the neonatal piglet
TW201137124A (en) Immunomodulatory compositions

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20160205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170619

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170619

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180425

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180522

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181022

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20181024

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190305

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190403

R150 Certificate of patent or registration of utility model

Ref document number: 6509833

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250